Zobrazeno 1 - 10
of 1 804
pro vyhledávání: '"Metabolic-associated fatty liver disease"'
Publikováno v:
Cardiovascular Diabetology, Vol 23, Iss 1, Pp 1-20 (2024)
Abstract Metabolic dysfunction-associated steatotic liver disease (MASLD), previously termed nonalcoholic fatty liver disease (NAFLD), poses a significant global health challenge due to its increasing prevalence and strong association with cardiovasc
Externí odkaz:
https://doaj.org/article/37d11f5ae2de418d90893f8a2fbe8674
Autor:
Xu Meimei, Han Sibo, Wu Qiaomei, Ma Shihong, Cai Huiying, Xue Mengqi, Liu Fengling, Xiao Xiaozhen, Chen Xiaoshuang, Lin MeiZhen
Publikováno v:
Open Life Sciences, Vol 19, Iss 1, Pp 2691-700 (2024)
The cardiometabolic index (CMI) is an emerging and effective indicator for predicting the presence of metabolic-associated fatty liver disease (MAFLD). This study aims to investigate the relationship between CMI and MAFLD using data from NHANES 2017
Externí odkaz:
https://doaj.org/article/559c6d3ea8864bda91a449ca26e61fcc
Publikováno v:
Diabetes, Metabolic Syndrome and Obesity, Vol Volume 17, Pp 3343-3354 (2024)
Shutong Ren,1,* Siyu Chen,2,* Jingru Huang,3 Rong Yu,1 Yunli Wu,4 Xian-E Peng1,4 1Department of Epidemiology and Health Statistics, Fujian Provincial Key Laboratory of Environment Factors and Cancer, School of Public Health, Fujian Medical Un
Externí odkaz:
https://doaj.org/article/d2c51332091941c2ad893954655e6fc1
Autor:
Louise Wutsdorff, Julienne Mougnekabol, Peter Tang, Anja Reutzel-Selke, Igor M. Sauer, Nils Haep
Publikováno v:
Livers, Vol 4, Iss 3, Pp 406-419 (2024)
Cell-death-inducing DNA fragmentation factor-alpha (DFFA)-like effector b (CIDEB) was first identified as an apoptosis-inducing protein. Further research revealed a pivotal role in lipid metabolism, regulating very-low-density lipoprotein (VLDL), lip
Externí odkaz:
https://doaj.org/article/f12feb41a2b449f9b5171a9036c71ded
Publikováno v:
Cardiovascular Diabetology, Vol 23, Iss 1, Pp 1-15 (2024)
Abstract Background Type 2 diabetes mellitus (T2DM) and metabolic-associated fatty liver disease (MAFLD) are both metabolic disorders that negatively impact the cardiovascular system. This study comprehensively analyzed the additive effect of MAFLD o
Externí odkaz:
https://doaj.org/article/d8f494d7d0384071987a9decbb04c39d
Publikováno v:
BMC Endocrine Disorders, Vol 24, Iss 1, Pp 1-8 (2024)
Abstract Background Follistatin-like protein 1 (FSTL1) has been identified as a secreted glycoprotein that plays an important role in obesity. However, its role in children with metabolic-associated fatty liver disease (MAFLD) has not been investigat
Externí odkaz:
https://doaj.org/article/29fb4cd8b6f8461f83922f0a5c097eec
Autor:
Heba Ahmed Osman, Sawsan M. A. Abuhamdah, Mohammed H. Hassan, Abdelkader Ahmed Hashim, Abdelazeem E. Ahmed, Sameh Salaheldin Elsayed, Samer A. El-Sawy, Mostafa A. Gaber, Marwa Abdelhady
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-12 (2024)
Abstract The prevalence of Metabolic-associated fatty liver disease (MAFLD) has been steadily increasing worldwide, paralleling the global epidemic of obesity and diabetes. It is estimated that approximately one-quarter of the global population is af
Externí odkaz:
https://doaj.org/article/338e4cfe6f1c4ad19b9aad178e87d8e7
Publikováno v:
BMC Gastroenterology, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background Glycotoxicity and lipotoxicity are key pathophysiological mechanisms underlying the development of metabolic associated fatty liver disease (MAFLD). The primary objective of this study is to investigate the association between the
Externí odkaz:
https://doaj.org/article/257ff45ed64245f293c1688d8aadf61e
Autor:
Negar Abdi, Hamid Ghaznavi
Publikováno v:
The Egyptian Journal of Radiology and Nuclear Medicine, Vol 55, Iss 1, Pp 1-6 (2024)
Abstract Background Liver injuries such as metabolic-associated fatty liver disease, liver fibrosis, and steatosis are common in COVID-19 patients. Unenhanced CT can be used to diagnose the morphological traits of steatosis and cirrhosis. This study
Externí odkaz:
https://doaj.org/article/39bf081af7fa41cc9fc0c8d4063b902a
Autor:
Jakub Hoferica, Ruben Zsolt Borbély, Ali Nedjati Aghdam, Eszter Ágnes Szalai, Ádám Zolcsák, Dániel Sándor Veres, Krisztina Hagymási, Bálint Erőss, Péter Hegyi, Peter Bánovčin, Péter Jenő Hegyi
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-13 (2024)
Abstract Chronic liver diseases (CLD) affect 1.5 billion patients worldwide, with dramatically increasing incidence in recent decades. It has been hypothesized that the chronic hyperinflammation associated with CLD may increase the risk of a more sev
Externí odkaz:
https://doaj.org/article/37f33251e7eb48e291745f8acf9bf8af